ArticleJournal of thoracic disease2022

Immune checkpoint inhibitors in neoadjuvant therapy of non-small cell lung cancer: a systematic review and meta-analysis.

Sa Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.